We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-0.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$52B
AUM Growth
-$1.61B
(-3%)
Cap. Flow
-$421M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
764
New
196
Increased
225
Reduced
259
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$109M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$92.2M |
| 3 |
Corning
GLW
|
+$81.5M |
| 4 |
IQVIA
IQV
|
+$62.7M |
| 5 |
Casella Waste Systems
CWST
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$715M |
| 2 |
Starbucks
SBUX
|
+$159M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$97.2M |
| 4 |
American Express
AXP
|
+$92.9M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
+$53.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.2% |
| 2 | Consumer Discretionary | 17.52% |
| 3 | Financials | 11.75% |
| 4 | Communication Services | 11.63% |
| 5 | Healthcare | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
TE Connectivity
TEL
$62.6B
| $62K | ﹤0.01% |
+669
| New | +$61.6K |
|
602
Trane Technologies
TT
$106B
| $62K | ﹤0.01% |
+505
| New | +$61.6K |
|
603
Verisk Analytics
VRSK
$25B
| $62K | ﹤0.01% |
+395
| New | +$61.3K |
|
604
Zimmer Biomet
ZBH
$18.4B
| $62K | ﹤0.01% |
+464
| New | +$59.9K |
|
605
Analog Devices
ADI
$190B
| $61K | ﹤0.01% |
+544
| New | +$61.6K |
|
606
Archer Daniels Midland
ADM
$36.9B
| $61K | ﹤0.01% |
+1,484
| New | +$59.1K |
|
607
Brown-Forman Class B
BF.B
$13.1B
| $61K | ﹤0.01% |
+971
| New | +$56.8K |
|
608
Clorox
CLX
$12.7B
| $61K | ﹤0.01% |
+401
| New | +$63.4K |
|
|
DFS
609
DELISTED
Discover Financial Services
DFS
| $61K | ﹤0.01% |
+752
| New | +$62.1K |
|
610
eBay
EBAY
$49.8B
| $61K | ﹤0.01% |
+1,559
| New | +$62.5K |
|
|
FITB
611
Fifth Third Bancorp
FITB
$51.8B
| $61K | ﹤0.01% |
+2,232
| New | +$61.2K |
|
612
Hilton Worldwide
HLT
$71.5B
| $61K | ﹤0.01% |
+658
| New | +$62.5K |
|
613
Jacobs Solutions
J
$17B
| $61K | ﹤0.01% |
+806
| New | +$57.7K |
|
614
Kraft Heinz
KHC
$30B
| $61K | ﹤0.01% |
+2,194
| New | +$63.1K |
|
615
Lam Research
LRCX
$390B
| $61K | ﹤0.01% |
+2,650
| New | +$55.6K |
|
616
Lumen
LUMN
$6.44B
| $61K | ﹤0.01% |
+4,916
| New | +$58.4K |
|
617
Northern Trust
NTRS
$33.9B
| $61K | ﹤0.01% |
+654
| New | +$60.1K |
|
618
Nucor
NUE
$62.1B
| $61K | ﹤0.01% |
+1,198
| New | +$62.5K |
|
619
Oneok
OKE
$54.5B
| $61K | ﹤0.01% |
+826
| New | +$58.5K |
|
620
Tyson Foods
TSN
$20.4B
| $61K | ﹤0.01% |
+703
| New | +$59.8K |
|
621
Williams Companies
WMB
$86.1B
| $61K | ﹤0.01% |
+2,517
| New | +$63.5K |
|
622
Willis Towers Watson
WTW
$32B
| $61K | ﹤0.01% |
+315
| New | +$61.5K |
|
|
WRK
623
DELISTED
WestRock Company
WRK
| $61K | ﹤0.01% |
+1,681
| New | +$60K |
|
624
Corteva
CTVA
$51.3B
| $60K | ﹤0.01% |
+2,131
| New | +$61.6K |
|
625
HCA Healthcare
HCA
$89.5B
| $60K | ﹤0.01% |
+496
| New | +$64.1K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2019 Portfolio in Review
As of Q3 2019, Loomis, Sayles & Company held 764 positions worth $52B, down 3% from $53.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q3 2019 filing shows 196 new, 225 increased, 259 reduced and 63 closed positions. Its largest new stake was IQVIA: 402,725 shares worth $60.2M. The largest sale was Bank of America Series L, an estimated $715M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q3 2019 buy was IQVIA: 402,725 shares worth $60.2M.
- Loomis, Sayles & Company added most to Monster Beverage in Q3 2019, an estimated $109M increase.
- Loomis, Sayles & Company's biggest Q3 2019 reduction was Bank of America Series L, cutting an estimated $715M.
- Loomis, Sayles & Company fully exited Wright Medical Group Inc in Q3 2019, selling an estimated $53.7M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $52B portfolio in Q3 2019.
- Loomis, Sayles & Company opened 196 new positions and closed 63 in Q3 2019.
- Loomis, Sayles & Company's portfolio value fell 3% quarter-over-quarter to $52B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2019, filed 13 Nov 2019.